Harvard Management Company’s Xilio Therapeutics XLO Stock Holding History

Harvard Management Company’s Portfolio XLO Stock Details XLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$878K	Hold
2023 Q2	$1.09M	Hold
2023 Q1	$1.32M	Hold
2022 Q4	$1.12M	Hold
2022 Q3	$1.21M	Hold
2022 Q2	$1.22M	Hold
2022 Q1	$2.94M	Hold
2021 Q4	$6.66M	Buy